Joanna Krakowiak: articles by this author
A change in the body responsible for issuing marketing authorisation for drugs should cut the time required to obtain approval in Poland.
Generics are substitutes for an original drug. May they be marketed as soon as the 10-year regulatory protection period for the original (innovative) drug ends?
Even though the European Court of Justice recently issued a negative opinion on the notion of a treaty that would establish a European and Community Patent Court…
A proposed new Act on Reimbursement for Medicinal Products, Foods and Medical Products calls for the Polish national health service to reimburse the costs of “special-purpose foods” when they offer documented health benefits.
An interview with Joanna Krakowiak from the Life Science and Regulatory Law practice group at Wardyński & Partners
Recent reports on disproportionate fees for doctors conducting clinical trials and the hospitals where they work are not the only problem. Conducting sometimes dozens of trials at one medical facility seriously reduces the quality of the research.